Al-Nouri Doha M
Department of Food and Nutrition Sciences, College of Food and Agriculture Sciences, King Saud University, Riyadh 11495, Saudi Arabia.
Pharmaceuticals (Basel). 2025 Apr 29;18(5):657. doi: 10.3390/ph18050657.
This study investigates the effects of cadmium chloride (CdCl) on hippocampal peroxisome proliferator-activated receptor gamma (PPARγ) expression and examines whether PPARγ activation mediates the neuroprotective effects of quercetin (QUR). Sixty adult male rats were included in this study, separated into 12 rats per group as follows: control, CdCl (0.5 mg/kg), CdCl + PPARγ agonist (Pioglitazone, 10 mg/kg), CdCl + QUR (25 mg/kg), and CdCl + QUR + PPARγ antagonist (GW9662, 1 mg/kg). Treatments were administered orally for 30 days. At the end of the experiment, behavioral memory tests, hippocampal histology, markers of cholinergic function, neuroplasticity, oxidative stress, inflammation, and apoptosis, as well as transcription levels of some genes were carried out. CdCl exposure significantly reduced hippocampal PPARγ mRNA and DNA binding potential and nuclear levels. Additionally, CdCl impaired spatial, short-term, and recognition memory, decreased granular cell density in the dentate gyrus (DG), and reduced levels of neuroprotective factors, including Nrf2, brain-derived neurotrophic factor (BDNF), acetylcholine (ACh), and several antioxidant enzymes including heme-oxygenase-1 (HO-1) and superoxide dismutase (SOD), as well as reduced glutathione (GSH). Conversely, CdCl elevated levels of oxidative stress, inflammation, and apoptosis markers such as interleukin-6 (IL-6), malondialdehyde (MDA), Bax, tumor necrosis factor-α (TNF-α), and cleaved caspase-3. QUR and Pioglitazone reversed these effects, restoring expression and PPARγ activation, improving memory, and modulating antioxidant and anti-inflammatory pathways. In contrast, blocking PPARγ with GW9662 negated the neuroprotective effects of QUR, exacerbating oxidative stress and inflammation by reversing all their beneficial effects. Activation of PPARγ by QUR or Pioglitazone offers a promising therapeutic strategy for mitigating CdCl-induced neurotoxicity.
本研究调查了氯化镉(CdCl)对海马体过氧化物酶体增殖物激活受体γ(PPARγ)表达的影响,并检验PPARγ激活是否介导了槲皮素(QUR)的神经保护作用。本研究纳入了60只成年雄性大鼠,每组12只,分组如下:对照组、CdCl(0.5毫克/千克)、CdCl + PPARγ激动剂(吡格列酮,10毫克/千克)、CdCl + QUR(25毫克/千克)以及CdCl + QUR + PPARγ拮抗剂(GW9662,1毫克/千克)。治疗通过口服给药,持续30天。实验结束时,进行了行为记忆测试、海马体组织学检查、胆碱能功能标志物、神经可塑性、氧化应激、炎症和凋亡相关指标,以及一些基因的转录水平检测。暴露于CdCl显著降低了海马体PPARγ的mRNA水平、DNA结合潜力和核水平。此外,CdCl损害了空间记忆、短期记忆和识别记忆,降低了齿状回(DG)中的颗粒细胞密度,并降低了包括Nrf2、脑源性神经营养因子(BDNF)、乙酰胆碱(ACh)在内的神经保护因子水平,以及包括血红素加氧酶-1(HO-1)和超氧化物歧化酶(SOD)在内的几种抗氧化酶水平,还有还原型谷胱甘肽(GSH)水平。相反,CdCl提高了氧化应激、炎症和凋亡标志物的水平,如白细胞介素-6(IL-6)、丙二醛(MDA)、Bax、肿瘤坏死因子-α(TNF-α)和裂解的半胱天冬酶-3。QUR和吡格列酮逆转了这些效应,恢复了表达和PPARγ激活,改善了记忆,并调节了抗氧化和抗炎途径。相比之下,用GW9662阻断PPARγ会抵消QUR的神经保护作用,通过逆转其所有有益作用而加剧氧化应激和炎症。QUR或吡格列酮激活PPARγ为减轻CdCl诱导的神经毒性提供了一种有前景的治疗策略。